These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 2516317)

  • 21. Synthesis of the pro-peptide of subtilisin BPN'.
    Cash PW; Zhu X; Ohta Y; Tsao J; Lackland H; Mateos-Nevado MD; Inouye M; Stein S; Jordan F; Tous GI
    Pept Res; 1989; 2(4):292-6. PubMed ID: 2520768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alteration of inhibitory properties of Pleurotus ostreatus proteinase A inhibitor 1 by mutation of its C-terminal region.
    Kojima S; Hisano Y; Miura K
    Biochem Biophys Res Commun; 2001 Mar; 281(5):1271-6. PubMed ID: 11243873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of two novel fibrinolytic enzymes from Bacillus subtilis QK02.
    Ko JH; Yan JP; Zhu L; Qi YP
    Comp Biochem Physiol C Toxicol Pharmacol; 2004 Jan; 137(1):65-74. PubMed ID: 14984705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Key elements for protein foldability revealed by a combinatorial approach among similarly folded but distantly related proteins.
    Morimoto S; Tamura A
    Biochemistry; 2004 Jun; 43(21):6596-605. PubMed ID: 15157092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selection of Streptomyces griseus protease B mutants with desired alterations in primary specificity using a library screening strategy.
    Sidhu SS; Borgford TJ
    J Mol Biol; 1996 Mar; 257(2):233-45. PubMed ID: 8609620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engineering substrate preference in subtilisin: structural and kinetic analysis of a specificity mutant.
    Ruan B; London V; Fisher KE; Gallagher DT; Bryan PN
    Biochemistry; 2008 Jun; 47(25):6628-36. PubMed ID: 18507395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient site-specific processing of fusion proteins by tobacco vein mottling virus protease in vivo and in vitro.
    Nallamsetty S; Kapust RB; Tözsér J; Cherry S; Tropea JE; Copeland TD; Waugh DS
    Protein Expr Purif; 2004 Nov; 38(1):108-15. PubMed ID: 15477088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The complete amino acid substitutions at position 131 that are positively involved in cold adaptation of subtilisin BPN'.
    Taguchi S; Komada S; Momose H
    Appl Environ Microbiol; 2000 Apr; 66(4):1410-5. PubMed ID: 10742220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant human cytomegalovirus protease with a C-terminal (His)6 extension: purification, autocatalytic release of the mature enzyme, and biochemical characterization.
    Tomasselli AG; Paddock DJ; Curry KA; Garlick RL; Leone JW; Lull JM; Mutchler VT; Baker CA; Cavey GS; Mathews WR; Shelly JA; Finzel BC; Baldwin ET; Wells PA; Tomich CS
    Protein Expr Purif; 1998 Dec; 14(3):343-52. PubMed ID: 9882568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reasoning enantioselectivity and kinetics of seleno-subtilisin from the subtilisin template.
    Häring D; Hubert B; Schüler E; Schreier P
    Arch Biochem Biophys; 1998 Jun; 354(2):263-9. PubMed ID: 9637735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pro-sequence of subtilisin can guide the refolding of denatured subtilisin in an intermolecular process.
    Zhu XL; Ohta Y; Jordan F; Inouye M
    Nature; 1989 Jun; 339(6224):483-4. PubMed ID: 2657436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of subtilisin BPN' by reaction site P1 mutants of Streptomyces subtilisin inhibitor.
    Kojima S; Nishiyama Y; Kumagai I; Miura K
    J Biochem; 1991 Mar; 109(3):377-82. PubMed ID: 1908859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular enzymes: gene regulation and structure function relationship studies.
    Jarnagin AS; Ferrari E
    Biotechnology; 1992; 22():189-217. PubMed ID: 1504587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineering a novel specificity in subtilisin BPN'.
    Rheinnecker M; Baker G; Eder J; Fersht AR
    Biochemistry; 1993 Feb; 32(5):1199-203. PubMed ID: 8448130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetic specificities of BPN' and Carlsberg subtilisins. Mapping the aromatic binding site.
    Karasaki Y; Ohno M
    J Biochem; 1978 Sep; 84(3):531-8. PubMed ID: 102640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved autoprocessing efficiency of mutant subtilisins E with altered specificity by engineering of the pro-region.
    Takahashi M; Hasuura Y; Nakamori S; Takagi H
    J Biochem; 2001 Jul; 130(1):99-106. PubMed ID: 11432785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant chymotrypsin inhibitor 2: expression, kinetic analysis of inhibition with alpha-chymotrypsin and wild-type and mutant subtilisin BPN', and protein engineering to investigate inhibitory specificity and mechanism.
    Longstaff C; Campbell AF; Fersht AR
    Biochemistry; 1990 Aug; 29(31):7339-47. PubMed ID: 2207109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel protease inhibitors via computational redesign of subtilisin BPN' propeptide.
    Daugherty AB; Muthu P; Lutz S
    Biochemistry; 2012 Oct; 51(41):8247-55. PubMed ID: 23009354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variants of subtilisin BPN' with altered specificity profiles.
    Rheinnecker M; Eder J; Pandey PS; Fersht AR
    Biochemistry; 1994 Jan; 33(1):221-5. PubMed ID: 8286344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal structure of calcium-independent subtilisin BPN' with restored thermal stability folded without the prodomain.
    Almog O; Gallagher T; Tordova M; Hoskins J; Bryan P; Gilliland GL
    Proteins; 1998 Apr; 31(1):21-32. PubMed ID: 9552156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.